Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com's coverage highlights our 3 biggest and most influential stories from the day's news to make sure you're up to date on the headlines that continue to shape the medical device industry.
Boston Scientific is on a regulatory roll, now touting CE Mark approval for its Agent drug-coated balloon for treatment of coronary artery disease.
Boston Scientific (NYSE:BSX) added another product to its recent string of regulatory approvals, announcing European CE Mark approval and immediate commercial launch for the company's Agent paclitaxel-coated balloon catheter.
Robot-assisted surgical devices maker Intuitive Surgical takes offense as doctors at a major U.S. cancer center warn that robot-assisted surgery may have little to offer patients undergoing surgical bladder removal.
The much-disputed field of robot-assisted surgery took another blow this week when doctors from Memorial Sloan Kettering Cancer Center warned that the high-tech procedure may be no better than traditional surgery for patients with invasive bladder cancer.